82 results
DEFA14A
COGT
Cogent Biosciences Inc
23 Apr 24
Additional proxy soliciting materials
4:34pm
Materials
Soliciting Material under § 240.14a-12
Cogent Biosciences, Inc.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s … with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
You invested in COGENT
8-K
EX-10.2
5q2 j4zkd
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
8-K
EX-10.1
cmb4rm5g4q3
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
424B5
m200fn1y hgty95h9ata
8 Jun 23
Prospectus supplement for primary offering
4:01pm
424B5
kdwlcow tbf
6 Jun 23
Prospectus supplement for primary offering
5:22pm
DEFA14A
k09kufaiazx3mm4gg
25 Apr 23
Additional proxy soliciting materials
4:06pm
424B5
z56x4o8vn7w
15 Jun 22
Prospectus supplement for primary offering
5:16pm
424B5
ldedvetrht
13 Jun 22
Prospectus supplement for primary offering
6:11am
DEFA14A
kkkcbxp2v6czl3b6v
26 Apr 22
Additional proxy soliciting materials
8:30am